FDA
- Status: approved
Recombinant antithrombin (rhAT) (Recombinant antithrombin (rhAT)) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Mayo Clinic is the originator. The local marketing authorisation holder may differ — check the official source linked above.